◀ Back to EPHB2

CX3CL1 — EPHB2

Text-mined interactions from Literome

Saitoh et al., Biochem Biophys Res Commun 2007 : The down-regulation of CX3CR1 mRNA correlated with the suppression of CX3CL1 induced activation of Akt and ERK as well as chemotaxis
Nevo et al., Cancer Lett 2009 (Neuroblastoma) : A dose dependent phosphorylation of ERK1/2 and AKT was induced in CX3CR1 expressing neuroblastoma cells by soluble CX3CL1
Ralay Ranaivo et al., Brain Res 2010 (MAP Kinase Signaling System) : Albumin activated ERK1/2 , p38 MAPK and JNK signaling pathways in astrocytes, and induced the production of interleukin (IL)-1beta, inducible nitric oxide (NO) synthase, the NO metabolite nitrite, and the chemokine CX3CL1 while reducing the level of S100B
Park et al., Transplant Proc 2012 (MAP Kinase Signaling System) : Fractalkine ( 50 ng/mL ) also induced cellular ROS production and activation of ERK1/2 and p38 MAPK in mesangial cells
Uchida et al., Lab Invest 2013 (MAP Kinase Signaling System...) : CX3CL1 release was suppressed by specific inhibitors of ERK , MMP, and ADAM, and ERK was associated with CX3CL1 transcription